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Benzene is well documented as an
environmental pollutant that can induce
hematotoxicity and hemopoietic neoplasia
in humans and mice (Aksoy et al. 1974,
1976; Cronkite et al. 1984, 1989; Snyder
et al. 1980; Vigliani and Forni 1976). To
date, studies on benzene have focused on
its metabolic pathways to determine the
metabolites responsible for its hematotoxi-
city and leukemogenicity (Henderson
1996; Schlosser et al. 1989; Schrenk et al.
1996; Snyder and Hedli 1996). Benzene
and its major metabolites are not muta-
genic in the Ames Salmonella test (Dean
1985), but they do induce chromosomal
aberration both in vitro and in vivo (Dean
1985; Wolman 1977; Yager et al. 1990).
This is comparable to classic carcinogens
that are generally being activated to a sin-
gle carcinogenic metabolite having a
mutagenic property. Benzene can be char-
acterized further in terms of its multisite
carcinogenicity (Huff et al. 1989; Maltoni
et al. 1989). Mice exposed to benzene
develop different types of tumor in
various glandular tissues and organs,
including the hemopoietic system,
Zymbal gland, Harderian gland, preputial
gland, mammary gland, ovary, and lung.
Results of the study of Low et al. (1995)
strongly suggest that the carcinogenicity
of benzene on target organs depends on
the ability of enzymes in the organs to
metabolize benzene.
As postulated by several investigators,
the metabolism of benzene to reactive
metabolites by hepatic enzymes, mainly
cytochrome P450-2E1 (CYP2E1), is a pre-
requisite to the cyto- and genotoxicities
associated with benzene exposure (Gut et al.
1996; Snyder and Hedli 1996; Valentine et
al. 1996). Primary benzene metabolites
include phenol, hydroquinone, catechol,
and trans-trans muconic acid (Ross 2000).
The synergistic interactions between these
phenolic metabolites exacerbate benzene
toxicity (Chen and Eastmond 1995;
Eastmond et al. 1987; Subrahmanyam et al.
1990). This mechanism of multimetabolite
genotoxicity is another unique aspect of
benzene that distinguishes it from other
chemicals in terms of the mechanism of its
toxicity and carcinogenicity. Benzene
metabolites subsequently undergo sec-
ondary activation by myeloperoxidase
(MPO) that is present at high levels in the
bone marrow tissue. This results in the pro-
duction of genotoxic quinones and reactive
oxygen species, thereby inducing not only
hemopoietic cellular damage (Farris et al.
1997; Kolachana et al. 1993; Lee and
Garner 1991; Smith et al. 1989) but also
the dysfunction of bone marrow stromal
cells (Niculescu et al. 1995).
Exposure duration and dose are also
important factors in determining benzene-
induced hematotoxicity and leukemogenic-
ity (Cronkite et al. 1989; Snyder and Kalf
1994), which may be related to the limited
capacity of enzymes for benzene metabo-
lism and to the dynamic responses of
hemopoietic microenvironmental condi-
tions against the adverse effects of benzene.
Despite intensive studies over several
decades, the mechanisms underlying ben-
zene-induced hematotoxicity and leuke-
mogenicity are still not fully understood.
Nevertheless, previous studies strongly
suggest that the toxic effects of benzene on
bone marrow tissue can be realized
through pathways such as those of metab-
olism (Snyder and Hedli 1996), growth
factor regulation (Niculescu et al. 1995),
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Although the mechanisms underlying benzene-induced toxicity and leukemogenicity are not yet
fully understood, they are likely to be complicated by various pathways, including those of
metabolism, growth factor regulation, oxidative stress, DNA damage, cell cycle regulation, and
programmed cell death. With this as a background, we performed cDNA microarray analyses on
mouse bone marrow tissue during and after a 2-week benzene exposure by inhalation. Our goal
was to clarify the mechanisms underlying the hematotoxicity and leukemogenicity induced by
benzene at the level of altered multigene expression. Because a few researchers have postulated
that the cell cycle regulation mediated by p53 is a critical event for benzene-induced hematotoxic-
ity, the present study was carried out using p53-knockout (KO) mice and C57BL/6 mice. On the
basis of the results of large-scale gene expression studies, we conclude the following: a) Benzene
induces DNA damage in cells at any phase of the cell cycle through myeloperoxidase and in the
redox cycle, resulting in p53 expression through Raf-1 and cyclin D-interacting myb-like
protein 1. b) For G1/S cell cycle arrest, the p53-mediated pathway through p21 is involved, as
well as the pRb gene–mediated pathway. c) Alteration of cyclin G1 and Wee-1 kinase genes may
be related to the G2/M arrest induced by benzene exposure. d) DNA repair genes such as Rad50
and Rad51 are markedly downregulated in p53-KO mice. e) p53-mediated caspase 11 activation,
aside from p53-mediated Bax gene induction, may be an important pathway for cellular apoptosis
after benzene exposure. Our results strongly suggest that the dysfunction of the p53 gene, possi-
bly caused by strong and repeated genetic and epigenetic effects of benzene on candidate leukemia
cells, may induce fatal problems such as those of cell cycle checkpoint, apoptosis, and the DNA
repair system, ﬁnally resulting in hemopoietic malignancies. Our cDNA microarray data provide
valuable information for future investigations of the mechanisms underlying the toxicity and
leukemogenicity of benzene. Key words: apoptosis, benzene, cDNA microarray, cell cycle, DNA
damage, DNA repair, hematotoxicity, leukemia, oxidative stress, p53-knockout mice. Environ
Health Perspect 111:1411–1420 (2003). doi:10.1289/txg.6164 available via http://dx.doi.org/
[Online 5 August 2003]production of oxidative stress (Laskin et al.
1996; Subrahmanyam et al. 1991), DNA
damage and repair (Lee and Garner 1991),
cell cycle regulation (Yoon et al. 2001b), and
apoptosis (Moran et al. 1996; Ross et al.
1996). These studies indicate that investiga-
tion of the roles of a few speciﬁc genes may
not be sufficient to explain the complete
molecular mechanism of benzene-induced
hematotoxicity and leukemogenicity.
Bone marrow tissue, a major target
organ of benzene, is an active hemopoi-
etic system in which various counterbal-
anced genes are organized through their
network interactions that maintain
cellular–environmental homeostasis as
well as protect cells from endogenous and
exogenous hematotoxic effects such as
benzene-induced effects. The dysregula-
tion of such a multidimensional counter-
balance, possibly induced by the genetic
and epigenetic effects of benzene, may
result in the altered expression of a num-
ber of genes associated with the mecha-
nisms of benzene-induced hematotoxicity
and leukemogenicity.
In this study we investigated the
changes in DNA expression during and
after benzene exposure (300 ppm) to probe
further the molecular mechanisms underly-
ing benzene toxicity. Because previous
studies (Boley et al. 2002; Yoon et al.
2001b) demonstrated that the p53 tumor
suppressor gene is important in cell cycle
regulation associated with the mechanisms
of benzene-induced toxicity, these analyses
were carried out by cDNA microarray
analyses in C57BL/6, wild-type (WT), and
p53-knockout (KO) mice.
Materials and Methods
Animals 
Specific pathogen–free, 7-week-old, male
C57BL/6 mice were purchased from Japan
SLC (Hamamatsu, Japan) and quarantined
for 1 week in 1.3-m3 inhalation chambers
(Shibata Scientific Technology Ltd.,
Tokyo, Japan) in ambient air. To obtain
WT and p53-KO mice for use in this
study, male and female heterozygous p53-
KO C57BL/6 mice, originally bioengi-
neered by Tsukada et al. (1993), were
mated; the pups produced were then iden-
tiﬁed by polymerase chain reaction analysis
of the DNA samples extracted from the
tail of each mouse. The mice were grouped
randomly into untreated control and
benzene-exposed groups and maintained
in stainless-steel wire cages inside inhala-
tion chambers under a 12-hr light–dark
cycle during the study. A basic pellet diet
(CRF-1; Funabashi Farm, Funabashi,
Japan) was provided ad libitum except
during the daily 6-hr benzene inhalation
period. Water was delivered by an
automated tubing nozzle and provided 
ad libitum throughout the study.
Benzene Exposure
Benzene vapor was generated and its
concentration was monitored as described
elsewhere (Yoon et al. 2001b). Temperature
and humidity inside the chambers were
maintained automatically at 24 ± 1°C and
55 ± 10%, respectively. Mice were exposed
to 300 ppm benzene for 6 hr/day,
5 days/week for 2 weeks; the sham control
groups were maintained in the inhalation
chambers in ambient air over the same
period. Experimental schedules for sham
and benzene-treated mice are shown in
Figure 1. Immediately after the ﬁrst 5 days
of exposure (D5), the second 5 days of
exposure in the second week (D12), and
3 days after D12 for recovery (D+3), the
mice were sacriﬁced. D12 is also designated
as the 2-week exposure. To investigate
changes in gene expression, three C57BL/6
mice from each of the sham control and
benzene-exposed groups were decapitated
after euthanasia at 1 week (D5) and
2 weeks (D12), respectively, during a
2-week benzene exposure period and
3 days after benzene removal (D+3), and
poly(A)+ RNA extracted from each group
was applied to Incyte gene expression
microarray (GEM) assay (Incyte Pharma-
ceuticals, Inc., Palo Alto, CA, USA) (see
“Microarray Preparation”). Our previous
study (Yoon et al. 2001b) showed that
mice are able to recover from benzene-
induced hematotoxicity 3 days after a
2-week benzene exposure. In studies using
WT and p53-KO mice, two to four mice
from each group and genotype were
sacrificed immediately after the 2-week
benzene exposure and applied to the
Affymetrix system (Affymetrix, Inc., Santa
Clara, CA, USA) (see “Microarray
Preparation”).
Bone Marrow Cell Collection for
RNA Extraction
The mice from which bone marrow cells
were collected for RNA extraction were
carefully chosen on the basis of our evalua-
tion of peripheral blood number and bone
marrow cellularity using a blood cell
counter (Sysmex M-2000; Sysmex Co.,
Tokyo, Japan) and our comparison of the
values with those previously reported
(Yoon et al. 2001b).
We harvested bone marrow cells from
both femurs of individual mice of each
group (Yoon et al. 2001b). Using a
27-gauge hypodermic needle, we flushed
out bone marrow cells of the bone shafts
with 2 mL Dulbecco’s modiﬁed minimum
essential medium without phenol red
(Invitrogen Corp., Carlsbad, CA, USA).
Single-cell suspensions were then prepared
by repeatedly passing the harvested bone
marrow cells through the needle. After the
lysis of red blood cells, the bone marrow
cells were immediately frozen in liquid
nitrogen and stored at –80ºC until RNA
extraction. 
Preparation of Total RNA and
Poly(A)+ RNA 
Total RNA was extracted from the
collected bone marrow cells using ISO-
GEN (Wako Chemical Co., Osaka, Japan)
in accordance with the manufacturer’s
instructions. The total RNA yielded optical
density (OD) ratios (OD 260/280) of
1.7–2.1; its purity was confirmed by gel
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Sham-control
Benzene-treated
1 45678 1 1 1 2 + 1 + 2 + 3
Affymetrix
Incyte GEM D5*
D12*
D+3* D12*
The days benzene was inhaled 6 hr/day, 5 days/week.
Figure 1. Benzene inhalation schedule diagram: exposure was for 6 hr/day from 10 A.M. to 4 P.M. On the
days marked with an asterisk (*), both sham exposure mice were killed at 4 P.M., and exposed mice were
killed immediately after exposure (Yoon et al. 2002). On D+3, both sham and recovery mice were killed at 4
P.M. D5 designates practically a 1-week exposure and D12, a 2-week exposure. D+3 is the group with a 3-
day recovery period after D12.chromatography, and its concentration was
determined on the basis of its absorbance at
260 nm that was measured with a
Beckman spectrophotometer (DU640;
Beckman Coulter, Inc., Fullerton, CA,
USA). Independent total RNA and
poly(A)+ RNA samples were separately
extracted from three C57BL/6 mice and
two to four WT and p53-KO mice; those
samples from equivalent materials were
analyzed using the Incyte GEM system and
the Affymetrix system. We used the
Affymetrix system to analyze further two
separate RNA samples from benzene-
exposed and sham-exposed WT mice at
each time point, and two separate RNA
samples from benzene-exposed and four
separate samples from sham-exposed p53-
KO mice. In addition, for further compari-
son, RNA samples from three mice in each
of the four groups were pooled and
processed with the Incyte GEM system.
No duplicate or triplicate runs were per-
formed using the Incyte GEM system.
Poly(A)+ RNA was prepared from the total
RNA using Oligo (dT) Microbeads
(Daiichi Co., Tokyo, Japan) in accordance
with the manufacturer’s instructions.
Microarray Preparation
All procedures such as experimental design,
array design, sampling, hybridization, sig-
nal measurements, and normalization con-
trol were performed according to the
MIAME (minimum information about a
microarray experiment) guidelines (Brazma
et al. 2001). 
Affymetrix system. Target preparation
from total mRNA. We synthesized the ﬁrst-
strand cDNA by incubating 40 µg total
RNA with 400 U SuperScript II reverse
transcriptase (Invitrogen), 100 pmol T7-
(dT)24 primer [5´-GGCCAGTGAATTG-
TAATACGACTCACTATAGGGAGGC
GG-(dT)24-3´], 1× ﬁrst-strand cDNA syn-
thesis buffer [50 mM Tris-HCl (pH 8.3),
75 mM KCl, 3 mM MgCl2, and 10 mM
dithiothreitol (DTT)], and 0.5 mM
deoxynucleoside 5´-triphosphate [dNTP:
mixture of 0.5 mM each deoxydenosine 5´-
triphosphate (TP), deoxycytidine TP,
deoxyguanosine TP, and deoxythymidine
TP] at 42°C for 1 hr. We synthesized the
second-strand cDNA by incubating the
first-strand cDNA with 10 U Escherichia
coli ligase (Invitrogen), 40 U DNA poly-
merase I (Invitrogen), 2 U RNase H
(Invitrogen), 1× reaction buffer [18.8 mM
Tris-HCl (pH 8.3), 90.6 mM KCl,
4.6 mM MgCl2, 3.8 mM DTT, 0.15 mM
nicotinamide adenine dinucleotide, and
10 mM (NH4)2SO4], and 0.2 mM dNTP
at 16°C for 2 hr. Ten units T4 DNA poly-
merase (Invitrogen) was added, and the
reaction was allowed to continue for
another 5 min at 16°C to generate the
blunt-ended double-stranded (ds) cDNAs.
After phenol/chloroform extraction and
ethanol precipitation, the ds-cDNA was
resuspended in 12 µL diethyl pyrocarbonate-
treated distilled water. Biotin-labeled
cRNAs were synthesized by in vitro tran-
scription using a BioArray HighYield RNA
transcript labeling kit (Enzo Diagnostics,
Farmingdale, NY, USA). The ds-cDNA
was then mixed with 1× HighYield reac-
tion buffer, 1× mixture solution of four
nucleoside TPs (NTPs: adenosine TP, cyti-
dine TP, guanosine TP, and uridine TP)
with biotin-labeled uridine TP and cyti-
dine TP, 1× DTT, 1× RNase inhibitor
mix, and 1× T7 RNA polymerase. The
mixture was incubated at 37°C for 4 hr,
with gentle mixing every 30 min. The
labeled cRNA was then purified using an
RNeasy minikit (Qiagen, Valencia, CA,
USA) in accordance with manufacturer
instructions. The purified cRNA was then
fragmented in 1× fragmentation buffer
(40 mM Tris–acetate, 100 mM potassium
acetate, and 30 mM magnesium acetate) at
94°C for 35 min.
Hybridization and scanning. For
hybridization, 15 µg of the fragmented
cRNA probe was incubated with 50 pM
control oligonucleotide B2, 1× eukaryotic
hybridization control (1.5 pM BioB, 5 pM
BioC, 25 pM BioD, and 100 pM cre),
0.1 mg/mL herring sperm DNA, 0.5 mg/mL
acetylated bovine serum albumin, and 1×
hybridization buffer in a 45°C rotisserie
oven for 16 hr. 
Probe array washing, staining, and
antibody ampliﬁcation. After hybridization,
washing and staining were performed with a
GeneChip ﬂuidic station (Affymetrix) using
appropriate antibody ampliﬁcation washing
and staining protocols.
Probe array scanning. The phycoery-
thrin-stained array was performed with a
confocal scanner (Agilent Affymetrix
GeneArray scanner), processed into digital
image files, and analyzed using the
Affymetrix analysis software Microarray
Suite (MAS, version 4.0).
Data normalization. GeneSpring
software (Silicon Genetics, Redwood City,
CA, USA) was used to normalize the data.
The 50th percentile of all measurements
was used as a positive control for the sam-
ple; each measurement for each gene was
divided by this synthetic positive control,
assuming that this was at least 10. The bot-
tom 10th percentile was used as a test for
correcting background subtraction. This
was never less than the negative values of
the synthetic positive control. The meas-
urement for each gene in each sample was
divided by the corresponding mean of the
sham controls, assuming that the cutoff
value is more than 0.01. 
Incyte GEM system. Fluorescence label-
ing of probe for GEM system. For compar-
ison of the array data obtained using the
Affymetrix system, the samples were simul-
taneously sent to the Incyte GEM system
to analyze the time course of gene expres-
sion changes after benzene inhalation and
its cessation. Poly(A)+ RNA (200 ng) from
each sample was sent to Incyte Co Ltd.
(MouseUniGEM: GEM-5200; Fremont,
CA, USA) via GEM custom screening ser-
vices (Kurabo Co Ltd., Osaka, Japan).
Brieﬂy, the samples were incubated for 2 hr
at 37°C with 200 U M-MLV reverse tran-
scriptase (Life Technologies, Gaithersburg,
MD, USA), 4 mM DTT, 1 U RNase
inhibitor (Ambion, Austin, TX, USA), 0.5-
mM dNTPs, and 2 µg 5´Cy3 or Cy5-
labeled 9-mers (Operon Technologies Inc.,
Alameda, CA, USA) in 25-µL volume with
an enzyme buffer supplied by the manufac-
turer, and then reverse-transcribed to
cDNA. The reaction was terminated by
heating at 85°C for 5 min. The paired reac-
tion mixtures were combined and purified
with a TE-30 column (Clonetech, Palo
Alto, CA, USA), diluted to 90 µL with dis-
tilled water, and precipitated with 2 µL of
1 g/mL glycogen, 60 µL of 5 M ammo-
nium acetate, and 300 µL ethanol. After
centrifugation, the supernatant was
decanted and the pellet was resuspended in
24 µL hybridization buffer, 5× sodium
chlorine–sodium citrate buffer, 0.2%
sodium dodecyl sulfate, and 1 mM DTT.
Hybridization. The probe solutions
were thoroughly resuspended by incubat-
ing them at 65°C for 5 min, with mixing.
The probe was applied to the array and
covered with a 22-mm2 glass cover slip and
placed in a sealed chamber to prevent evap-
oration. After hybridization at 60°C for
6.5 hr, the slides were consecutively washed
3 times in a washing buffer of decreasing
ionic strength.
The GEM system scanning. After
hybridization, the GEM was scanned at
10-µm resolution to detect Cy3 and Cy5
fluorescence. Both Cy3 and Cy5 channels
were scanned simultaneously with indepen-
dent lasers. The emitted fluorescent light
was optically filtered before photo-multi-
plier tubes translated the photons into an
analog electrical signal, which was further
processed into a 16-bit digital signal. This
provided electronic images of both Cy3
and Cy5 with a 65,536-color resolution. A
16-color log scale was used for visual
representation.
Normalization and ratio determination.
Incyte GEM Tool software (Incyte) was
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detection algorithm was used to determine
the elements. The area surrounding each
element image was used to calculate the
local background and was subtracted from
the total element signal. Background-
subtracted element signals were used to cal-
culate the Cy3:Cy5 ratio. The average of
the resulting total Cy3 and Cy5 signals
gives a ratio that is used to balance or
normalize the signals.
Results of cDNA Microarray
Analyses and Their
Implications
In this study we investigated the changes in
gene expression during and after benzene
exposure (300 ppm). As previous studies
(Yoon et al. 2001b) demonstrated that the
p53 tumor suppressor gene plays an impor-
tant role in a cell response to benzene toxi-
city, analyses were performed using WT
and p53-KO mice. In the sections that fol-
low, we compare the gene expression pro-
file obtained from WT mice using the
Incyte GEM system with that obtained
using the Affymetrix system, which in turn
are compared with those of previous
reports (Boley et al. 2002; Ho and Witz
1997; Schattenberg et al. 1994, Zhang et
al. 2002). In addition we also describe par-
ticular genes related to p53-KO mice, such
as cell cycle–regulating genes, apoptosis-
related genes, and DNA repair–related
genes.
All gene names, abbreviations, and
accession numbers from MAS 4.0 are
equivalent to those of GenBank (http://
www.ncbi.nlm.nih/gov/Genbank/
index.html).
Gene Expression Proﬁle of Wild-
Type Mice after Benzene Exposure
Figure 2 shows differences in the expression
patterns of specific genes between, during,
and after exposure of the WT mice to 300
ppm benzene for 2 weeks, determined using
the Incyte GEM system (see Figure 1 for
experimental schedule). Figure 2A shows
the genes upregulated during benzene expo-
sure (D5, D12), and then downregulated
afterward (D+3), as represented by the
MPO gene. Figure 2B shows the genes that
had been continuously upregulated after
benzene exposure, i.e., p53-binding protein
1 (53BP1), adenosine triphosphate (ATP)–
binding cassette (ABC) transporter, and
N-acetylglucosamine-6-O-sulfotransferase.
Figure 2C shows the genes that had contin-
uously been somewhat upregulated after
benzene exposure, e.g., murine cathelin-like
protein (MCLP), cell division cycle 2
(cdc2), and lipocalin 2. The expression pat-
terns of MPO in Figure 2A may be induced
by benzene metabolism during benzene
exposure. This induction ceases after inhala-
tion (Schattenberg et al. 1994), whereas
53BP1, a DNA damage–responsive gene
(Ward et al. 2003), and ABC transporter, a
detoxifying drug–transporter (Ambudkar
and Gottesman 1998), in Figure 2B show
prolonged expressions after benzene expo-
sure. MCLP (Gombert et al. 2003) and
lipocalin 2 (Jessen and Stevens 2002) func-
tion as marker genes for differentiation.
The genes listed in Figure 2C, including
cdc2, may be upregulated for the prolifera-
tion of bone marrow cells during the recov-
ery phase. A particular expression change in
the aryl hydrocarbon receptor (AhR) was
observed for which a mechanism could not
be speciﬁed (data not shown). As we previ-
ously observed, sensitivity to benzene toxic-
ity is innate in AhR-KO mice, implying
that AhR transmits this sensitivity to
benzene toxicity (Yoon et al. 2002). 
The results of cDNA microarray
analysis showed a broad consensus that
the p53 tumor suppressor gene is central
to the mechanism of benzene action, by
strictly regulating specific genes involved
in the pathways of cell cycle arrest, apop-
tosis, and DNA repair. Such close associ-
ation of the p53 gene with the benzene
toxicity mechanism raises the question:
What would happen in mice whose p53
gene is knocked out after benzene expo-
sure? Thus, the cDNA microarray data
obtained from the WT and p53-KO mice
were applied to the Affymetrix system
and analyzed using GeneSpring software,
as described in “Materials and Methods.”
The results are shown in Table 1. This
table shows that the expression profiles of
the many genes involved in benzene
metabolism, cell cycle or cell prolifera-
tion, and hemopoiesis in WT mice were
generally consistent with the cDNA
microarray data of C57BL/6 mice
described in Table 2.
Characteristics of Gene Expression
Proﬁle of p53-KO Mice after
Benzene Exposure
Mice lacking the p53 gene and WT mice
generally had similar expression patterns
of the genes involved in benzene metabo-
lism (CYP2E1 and MPO; Bernauer et al.
1999, 2000; Schattenberg et al. 1994;
Yoon et al. 2001b) and hemopoiesis, sug-
gesting that p53-KO mice are also
affected to a similar extent by benzene
exposure. This is consistent with the high
frequency of micronuclei observed in
benzene-exposed p53-deficient mice
(Healy et al. 2001) (Table 1, Table 3A;
p53-independent, benzene-induced gene
expression level increase or decrease.).
Figure 3 shows scatterplots representing
the expression levels of genes in the bone
marrow cells of the benzene-exposed WT
(Figure 3A) and p53-KO mice (Figure
3B) relative to the expression levels of the
genes in those of the corresponding
sham-control mice. To elucidate and
visualize the difference in gene expression
level between the WT and p53-KO mice,
clustering analysis was performed (Figure
4). The genes expressed include cell
cycle/proliferation–associated genes.
Table 3B lists the genes with a p53-
dependent, benzene-induced decrease
(e.g., G protein–coupled receptor
[GPCR]) or increase (e.g., caspase-11) in
expression level in the WT mice. In the
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Figure 2. Three different expression patterns are shown along the time course. Benzene was used to
expose the mice at 300 ppm for 1 week (D5) and 2 weeks (D12). D+3 designates the recovery group. The
Incyte GEM system was used. Background-subtracted element signals were used to calculate the
Cy3:Cy5 ratio. (A) Genes upregulated during the benzene exposure followed by immediate downregulation
after benzene exposure: MPO (GenBank accession number X15313, [■]), MPO (GenBank accession num-
ber X15378, [◆]). (B) Genes upregulated during and after benzene exposure: N-acetylglucosamine-6-O-
sulfotransferase (■), ABC transporter (◆), 53BP1 (●). (C) The genes were gradually or immediately
upregulated after the benzene exposure, chieﬂy represented by DNA repair and proliferation during the
recovery phase; MCLP (■), cdc2 (◆), lipocalin 2 (●).Toxicogenomics | Mechanisms of benzene-induced hematologic toxicity
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Table 1. Gene expression proﬁles in WT and p53-KO mice. Mice were exposed to 300 ppm benzene for 6 hr/day, 5 days/week, for 2 weeks, and killed on day 12.a
Fold change Accession
Category Gene nameb WT KO number
Cell cycle Calcyclin 1.08 1.89 X66449
Cyclin B1 0.85 1.48 X64713
Cyclin D3 0.83 1.20 M86186
Cyclin G1 1.67 1.32 L49507
Dmp1 2.01 2.81 U70017
Gadd 45c 1.63 (—) U00937
JNK2 1.07 1.82 AB005664
KSR1; protein kinase related to Raf protein kinase 1.11 2.57 U43585
mLimk1; Mus musculus protein kinase 2.67 1.18 X86569
Mph1/Rae 28; polycomb binding protein 4.97 0.06 U63386
Nsg1; similar to mouse p21 2.45 1.83 AV347030
p21c 1.37 (—) U09507
p53 1.03 0.13 U59758
PERK 0.81 1.63 AF076681
SNK; serum inducible kinase 1.68 1.02 M96163
Tsc-2 2.00 1.25 U37775
Wee-1c 1.95 (—) D30743
Wig-1; p53-inducible zinc ﬁnger protein 1.83 0.07 AF012923
Growth factor EGFB-3; epidermal growth factor binding protein 3 1.92 0.69 M17962
GPCR; EB11 0.01 0.97 L31580
Growth hormone 0.99 1.73 X02891
IGFBP-6 (s) 2.88 0.10 X81584
PGRP; tumor necrosis factor super family 3-like 0.95 1.80 AF076482
Placental growth factor 1.13 2.14 X80171
DNA damage /repair Rad50 1.23 0.40 U66887
Rad51 0.72 0.08 AV311591
Apoptosis Apaf-1 1.16 1.75 AF064071
Bax-alpha 1.20 1.21 L22472
Bcl-2 alpha 0.91 1.66 L31532
Caspase-9 0.83 1.59 AB019600
Caspase-9S 0.84 2.26 AB019601
Caspase-11 2.49 1.22 Y13089
Caspase-12 0.86 0.18 Y13090
ELK1; member of ETS oncogene family 1.33 2.06 X87257
Metaxin2 0.95 1.55 AF053550
p58; protein kinase inhibitor (PKI) 1.55 0.81 U28423
Smad6 1.36 1.92 AF010133
Siva (proapoptotic protein) 0.88 1.62 AF033115
WISP1 0.68 1.26 AF100777
WISP2 0.83 8.32 AF100778
Oxidative stress Aldehyde dehydrogease 4 1.07 2.44 U14390
Cox5b 1.07 1.56 X53157
Cox7a-L 0.97 1.51 AF037371
Cui/Zn-SOD 1.19 1.63 M35725
Glyceraldehyde-3-phosphate dehydrogenase 1.06 3.34 M32599
LDH1; lactate dehydrogenase 1 1.13 2.34 AW123952
LDH2; lactate dehydrogenase 2 0.97 1.72 X51905
Metallothionein 1 4.89 0.93 V00835
Metabolic enzyme  CYP2E1 2.13 1.72 X01026
CYP7B1 1.84 1.11 U36993
MPO; myeloperoxidase 1.68 1.49 X15378
Hemopoiesis ALK-1; TGF-beta type 1 receptor 2.53 2.71 Z31664
Beta-spectrin 3 1.78 0.87 AF026489
CD3-theta T cell receptor 1.07 2.37 L03353
Fra-2; fos-related antigen 2 1.78 1.78 X83971
IL-4 0.91 1.95 M25892
M-CSF; macrophage colony-stimulating factor 1.03 2.13 M21952
Mac-1 alpha 0.74 1.93 X07640
Mg11; IFN-induced 0.88 1.75 U15635
MTCP-1; mature T cell proliferation 1 1.52 1.28 Z35294
NFAT-1; nuclear factor of activated T cells 1 0.60 2.02 U36576
Phospholipase A2 1.35 1.77 U18119
PI3K catalytic subunit p110 delta 2.36 0.18 U86587
S100 calcium-binding protein A13 1.24 1.78 X99921
STAT5B 0.91 1.74 AJ237939
TCF; T-cell factor, alternatively spliced 1.00 2.11 AF107298
TNFRrp; lymphotoxin-beta receptor 2.06 1.71 L38423
Nr1il; vitamin D receptor 2.54 1.60 D31969
Oncogene Fes 0.81 1.79 X12616
c-fos 1.57 0.94 V00727
RAB17; member of RAS oncogene family 2.42 1.53 X70804
Wnt-1/INT-1 1.72 1.23 M11943
Fatty acid β-oxidation Acyl-CoA thioesterase 2.44 0.38 Y14004
Adipose fatty acid binding protein 1.75 1.25 M20497
aThe studies involved two to four animals; data were obtained from the use of the Affymetrix gene chips. Mice were killed on day 12, immediately after benzene exposure (see Figure 1,
“Experimental Schedule”). bInformation for GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html). cNo data available for p53-KO mice.  p53-KO mice, these genes did not change
their expression level with benzene expo-
sure. Table 3C shows that some changes in
gene expression were undetectable because
of the function of the p53 gene, which can
be “visualized” in the p53-KO microarray
(Figure 4). Namely, data from toxicoge-
nomics studies of specific gene KO mice
could possibly disclose homeostatic bal-
ances undetectable in conventional
WT mice. 
Cell Cycle–Regulating Genes in p53-
KO Mice and Wild-Type Mice
Cyclin genes were generally activated in
p53-KO mice after benzene exposure,
whereas cell cycle–regulating genes
including the G2/M arrest-related gene
cyclin G1 (Kimura et al. 2001) were
upregulated in WT mice. These findings
indicate that the hemopoietic cell cycle is
still functional in p53-KO mice during
benzene exposure, whereas in WT mice it
is arrested because of alterations in the
expression of cell-cycle checkpoint genes,
particularly the p53 gene (Yoon et al.
2001b).
Some upstream genes encoding p53,
such as Dmp1 and Raf-1 of the p53-KO
mice, compared with those of the corre-
sponding experimental groups of the WT
mice, were upregulated to a similar extent
or were more strongly enhanced in their
expression. This is another indication of
the role of the p53-mediated pathway in
the mechanism of benzene toxicity associ-
ated with cell cycle regulation. Such infor-
mation could be important in helping
investigators to understand yet unknown
mechanisms of chemical toxicity.
It is important to note that such a con-
clusion possibly can be drawn by carefully
and simultaneously screening different
expression patterns of many genes with
interrelated functions, including genes
showing small changes in expression levels
(about 1.5- to 2-fold). The investigation
of the expression levels of a limited num-
ber of genes generally may not provide
insight into the main mechanism of
chemical toxicity or clues to the particular
role of each of the investigated genes in
this mechanism. Toxicogenomics may
have a strong advantage from this point of
view (Inoue 2003).
Apoptosis-Related Genes in p53-KO
Mice and Wild-Type Mice 
The microarray analysis results of the
p53-KO mice reminded us of the impor-
tance of the p53 gene in the mechanism of
benzene toxicity. The genes activated by
the p53 gene, including p21, caspase 11
(Choi et al. 2001; Kang et al. 2000), and
cyclin G1 (Kimura et al. 2001), were dis-
tinctly upregulated in the benzene-exposed
WT mice (Table 1). It is interesting that
caspase 11 instead of caspase 9 was highly
expressed after benzene exposure. This sug-
gests that the p53-mediated activation of
caspase 11 is an important signaling
pathway of apoptosis of bone marrow cells
Toxicogenomics | Yoon et al.
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Table 3. Differences in alteration of gene expression between WT and p53-KO mice after benzene exposure.
Expression category Gene abbreviationsa
A.  p53-independent benzene-induced decrease or increase
Decrease CR6, EGFBP-1, GDIA, GDI-alpha, mGk-6, Glut-3, HDGF, PKD1, ZO-1
WT: decreased
p53-KO: decreased
Increase ALK-1, Angrp, cardiac troponin T, Ctsg, CYP2E1, Dmp1, Fmo3,
WT: increased fra-2, GHR, Gpr50, Hox-1.7, KIK-I, MPO, NEFA protein, NrLi1,
p53-KO: increased Nsg-1, PN-1, RAB17, Sim1, Sox10, Tip30, TNFRrp, WBP9
B.  p-53-dependent benzene-induced decrease or increase
Decrease Adcy6, ApoE, AQ1, B cell antigen receptor, Cam III, CCR9, E2F1,
WT: decreased FATP4, Fscn1, GPCR (EB11), Ig kappa light chain, IgA, IgH,
p53-KO: unchanged mur42, Pdk1, PPT-B, Prkm1, TP, TRBF1
Increase Adipose fatty acid binding protein, Adh-3, caspase-11, cyclin G1,
WT: increased CYP7B1, EGFB-3, emp-1, FKBP23, c-fos, Hox-4.9, Int-1, Lfc,
p53-KO: unchanged Krtl-12, mLimk1, MDC2, Mtcp1, Nr2b1, p58 (PKI), Pcnt, PFK,
Pkacb, PGII, PTG, beta-spectrin, SPI-3, SNK, TSC-2
C.  p53-KO–related decrease or increase by benzene exposure but no changes in the WT mice
Decrease CalDAG-GEFI, Cbfa2, Dctn1, Fr1, Grl-1, Ig/EBP, Klra3, Mek5,MEP,
WT: unchanged
p53-KO: decreased
Increase 24p3, 4E-BP2, Abcg2, ACRP, activine, Ahd3, Alp, Anx3, AOE372,
WT: unchanged Apaf1, BAG-1, BAP, bcl-2, calcyclin, canexin, caspase 9, COX8H,
p53-KO: increased caspase 9S, CCR1, CD3 theta, CD71, CD143, Cox5b, Cox7a1,
Ctla-2a, Cu/Zn-SOD, cyclin B1, DCIR, Dnmt2, Dpagt2, E4BP4,
EPO, FACS, Fes, elk1, G6PD, G6PD-2, Galbp, Gapdh, Gcdh, Gdi2,
growth hormone, Gnb-1, Gng3lg, H-2T18, HES-1, IGF-1, IL1bc,
IL-4, IL-9, JSR1, LDH-1, LDH-2, mLigI, Lipo 1, Lrf, Ly-3, Ly-40,
Jam, JNK2, Kcc1, KSR1, M-CSF, Mac-1 alpha, Mch6, Mg11,
MHR23A, MmCEN3, Mrad17, MRP14, Mtx2, NFATp, NL, Nmo1,
OERK, PAFR, Pde8, PERK, PGRP, Pla2g2c, PLGF, Pop2, Prkm9,
Prtn3, RBP-L, Rga, S100A13, Siva, Smad 6, SPRR2J, Stat4, 
Stat 5B, TCF4, TOM1, trypsin 2, Tst
aInformation for GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html). 
Table 2. Expression proﬁles of the genes.
Category Gene namea Reference
Metabolic enzyme CYP2E1 Zhang et al. 2002
MPO Schattenberg et al. 1994
Cell cycle p53 Boley et al. 2002
p21 (waf 1) Boley et al. 2002
Cyclin G Boley et al. 2002
Gadd 45 Boley et al. 2002
Apoptosis Bax-alpha Boley et al. 2002
Oncogene c-fos Ho and Witz 1997
aInformation for GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html). triggered by benzene exposure. This novel
observation associated with the benzene
toxicity mechanism together with the
downmodulation of caspase 12 was
similarly addressed using WT and p53-KO
mice in the study of the mechanism of
chronic obstructive urinary disturbances
(Choi et al. 2001). The decrease in the
expression level of caspase 12 in the p53-
KO mice after benzene exposure seems to
be in good agreement with the previous
report on caspase 12 regulation by p53
(Choi et al. 2001).
Genes associated with oxidative stress
were both up- and downregulated in the
p53-deficient mice, which may be an
indication of benzene-induced oxidative
stress (Yoon et al. 2001a; Table 1). It is
not clear why oxidative stress–associated
genes are activated in p53-KO mice and
not in WT mice, but this might reflect
the deregulation of the redox cycle due to
the absence of the p53 gene and the con-
secutive counteractivation of antioxidant
enzymes (Chandel et al. 2000). Apoptotic
protease-activating factor 1 (Apaf-1),
metaxin, and Siva genes were also upreg-
ulated in the benzene-exposed p53-KO
mice (Table 1). The expression of these
genes may suggest proapoptotic condi-
tions induced by benzene exposure of
p53-KO mice. However, survival or anti-
apoptosis genes such as bcl-2, caspase 9S
(an endogenous dominant negative of cas-
pase 9) (Seol and Billiar 1999), and
Smad6 (antagonist of tumor growth fac-
tor-β [TGF-β] signaling) (Imamura et al.
1997) are also activated in p53-KO mice.
PERK (endoplasmic reticulum resident
kinase) upregulation in p53-KO mice
indicates the triggering of the unfolded
protein-response signaling pathway,
resulting in the loss of cyclin D1 (Brewer
and Diehl 2000).
Expression of DNA Repair–Related
Genes in p53 Gene Network 
Despite the possible damage to the DNA
of the bone marrow cells of a p53-KO
mouse, the DNA repair system is not
likely to be functioning efficiently in the
p53-KO mice, as DNA repair–related
genes that were actively functioning in the
benzene-exposed WT mice were not acti-
vated but rather suppressed in the p53-KO
mice. In association with cell proliferation
and apoptosis, high expression levels of the
tuberous sclerosis gene (Tsc-2), a tumor
suppressor gene encoding tuberin, and
metallothionein 1 gene were noted in the
WT mice (Table 1), raising the possibility
that these genes are regulated by the p53
gene. The association of metallothionein
with p53 transcriptional activity has
Toxicogenomics | Mechanisms of benzene-induced hematologic toxicity
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Figure 3. Scatterplots representing expression of genes in the bone marrow cells of benzene-exposed WT
(A) and p53-KO mice (B) relative to expression of the genes in those of the corresponding sham-control
mice, obtained using the Affymetrix system; x-axis and y-axis, respectively, indicate fluorescent signal
intensity in the sham-control and benzene-exposed groups.
PERK
Cyclin B1
Siva
Calcyclin
JNK2
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Figure 4. Clustering diagram of gene trees focused on particular genes of interest in the Affymetrix sys-
tem. GeneSpring software was used to normalize the data. Clustering of microarray data revealed the
standardized expression intensities of relevant genes shown by colors; from low expression level to high
expression level, blue < yellow < orange < red. WT mice with or without benzene exposure, as well as
p53-KO mice with or without benzene exposure are compared. A cluster of genes in the box (top) was
found to consist of genes, the functions of which are related to cellular proliferation (bottom), and
expressed only when p53 is knocked out, after benzene exposure. The average expression levels were
obtained from two to four independent RNA samples from the mice. Genes in the box (top) are listed at
the bottom; from the top: PERK (GenBank accession number AF076681), cyclinB1 (GenBank accession
number X64713), Siva (GenBank accession number AF033115), calcyclin (GenBank accession number
X66449), JNK2 (AB005664), growth hormone (GenBank accession number X02891), PGRP (GenBank
accession number AF076482), Mg11 (GenBank accession number U15635). recently been postulated in an in vitro sys-
tem in which metallothionein acts as a
potent chelator to remove zinc from p53,
thereby modulating p53 transcriptional
activity (Meplan et al. 2000). The Tsc-2
gene has recently been reported to regulate
the insulin-signaling pathway mediated by
protein kinase B (PKB/Akt) for cell
growth (Gao and Pan 2001; Potter et al.
2002). It is noteworthy that Tsc-2 is a tar-
get gene of 2,3,5-tris (glutathion-S-y)
hydroquinone, a metabolite of hydro-
quinone for renal cell transformation (Lau
et al. 2001). The high expression level of
the mph1/rae28 gene in the WT mice with
severely suppressed bone marrow cellular-
ity is noteworthy with respect to the main-
tenance of the activity of hemopoietic stem
cells (Ohta et al. 2002). Furthermore, the
Wnt-1 signaling pathway is also likely to
be activated after benzene exposure, fol-
lowed by the aberrant expressions of
downstream genes such as WISP1 and
WISP2 (Table 1). As the Wnt-1 signaling
pathway was reported to regulate the
proliferation and survival of various types
of cell including B lymphocytes (Reya et
al. 2000), the activation of both
mph1/rae28 and Wnt-1 genes may be asso-
ciated with the rapid recovery of sup-
pressed bone marrow cellularity after
cessation of benzene exposure. 
Summary 
As described above, the results of our
cDNA microarray suggest that p53-KO
mice are not resistant to benzene-induced
toxic effects. These results were compara-
ble with the dynamic protective responses
of C57BL/6, WT mice at the gene func-
tional level. On the basis of these observa-
tions, the effects of benzene on the bone
marrow cells of p53-KO mice can be sum-
marized as follows: a) cellular damage due
to benzene metabolites and oxidative
stress, b) dysfunction of the machinery of
cell cycle arrest for repairing damaged
DNA, resulting in continuous cycling of
damaged cells even without undergoing
repair, c) inhibition of apoptosis by both
disruption of p53-dependent proapoptotic
signaling and activation of survival genes,
and d) failure of activating DNA repair
genes. Such phenomena may lead to the
increase in cell mutation frequencies at
the candidate DNA locus, for instance,
the hprt locus, responsible for benzene
carcinogenesis, resulting in the develop-
ment of hemopoietic malignancies. This
hypothesis is based on multigene expres-
sion profiles that reasonably explain the
high incidence and early onset of hemo-
poietic neoplasia, which were clearly
observed in the p53 hetero- and homozy-
gous KO mice chronically exposed to a
critical dose of benzene for leukemogenic-
ity tests (Kawasaki et al. Unpublished
observation).
We also noted that the genes involved
in fatty acid β oxidation such as the acyl-
Co-A thioesterase gene and those encod-
ing adipose fatty acid–binding proteins,
which are commonly induced by peroxi-
some proliferators such as diethylhexyl-
phthalate and clofibrate (Bartosiewicz
et al. 2001), were also upregulated in the
WT mice exposed to benzene (Table 1).
A possible signaling pathway induced by
benzene exposure is shown by a schematic
in Figure 5. The present study using p53-
KO mice elucidated the role of the p53
gene not only in during benzene expo-
sure, but also in the recovery state, and
the gene expression profiling from p53-
KO mice visualizes such oscillatory
changes hidden behind the homeostatic
balance organized by the p53 gene in
WT mice.
In conclusion, The cDNA microarray
system used in this study revealed the
mechanism of benzene toxicity by showing
the altered expression of a number of ben-
zene-affected genes including physiologic
and toxicologic gene repertoires. Our data
will provide valuable targets for the future
investigation of the mechanism of benzene-
induced toxicity and leukemogenicity.
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